Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 37 Prostatic Neoplasms 12 Triple Negative Breast Neoplasms 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Liver Neoplasms 3 Fibrosis 3 Endometrial Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Intraductal, Noninfiltrating 3 Uterine Cervical Neoplasms 2 Thyroid Nodule 2 Stomach Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pleural Effusion, Malignant 2 Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Lymphoma 2 Lymphedema 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Inflammatory Breast Neoplasms 2 Infertility 2 Hodgkin Disease 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Medullary 2 Carcinoma, Hepatocellular 2 Anatomic Stage III Breast Cancer AJCC v8 2

Interventions

Megestrol Acetate 9 Exercise 6 Standard of Care 4 Blood Specimen Collection 4 Olanzapine 3 Ibuprofen 3 dermcidin 2 anamorelin 2 Resistance Training 2 Physical Therapy Modalities 2 Nutrition Assessment 2 Mirtazapine 2 Melatonin 2 Infliximab 2 Enteral Nutrition 2 Dietary Supplements 2 Diet Therapy 2 Cyproheptadine 2 testosterone enanthate 1 telotristat ethyl 1 remune 1 ostarine 1 olanzapine-fluoxetine combination 1 nabiximols 1 nabilone 1 irinotecan sucrosofate 1 fucoidan 1 clazakizumab 1 bermekimab 1 alkaloid GB18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cachexia × High-Energy Shock Waves × Clear all

NCT03982082 2025-01-15

Ultrasound in Evaluating Muscle-Glycogen Content in Cancer Patients

M.D. Anderson Cancer Center

Phase NA Completed

Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡